Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02280564 · ClinicalTrials.gov registry record · NA
Study of A Cell-Phone System to Improve Health of Youth With Diabetes
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT02280564 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 74 participants.
The verdict
NCT02280564, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
FL3X is an integrated diabetes self-management system that incorporates modern cell phone technology with behavioral modification approaches to improve diabetes self-management in high-risk youth. Utilizing such approaches will increase adherence to diabetes management behaviors and improve glucose control by providing increased autonomy over diabetes care.
Interventions
- BEHAVIORAL health coaching with technology support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2011-03 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02280564
The ClinicalTrials.gov registry entry for NCT02280564 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which health coaching with technology support is the first listed.
NCT02280564 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02280564 about?
NCT02280564 is a clinical study titled "Study of A Cell-Phone System to Improve Health of Youth With Diabetes". FL3X is an integrated diabetes self-management system that incorporates modern cell phone technology with behavioral modification approaches to improve diabetes self-management in high-risk youth. Utilizing such approaches will increase adherence to diabetes management behaviors and improve glucose ...
What is the current status of trial NCT02280564?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2011-03. Estimated completion is 2013-03.
What interventions are being tested in trial NCT02280564?
The interventions under investigation include: health coaching with technology support (BEHAVIORAL).
Who is sponsoring clinical trial NCT02280564?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.